Analyst Research

Report Title Price
Provider: Reuters Investment Profile
£10.00
Provider: Investcafe
£15.00
Provider: Investcafe
£15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

FAS Clears AFK Sistema OAO's Bid To Buy Stake In Veropharm OAO From Aptechnaya set' 36,6 OAO-Reuters


Monday, 12 Nov 2012 

Reuters reported that Russia's anti-monopoly regulator FAS cleared AFK Sistema OAO's (Sistema) plan to buy 100% of voting shares in drug maker Veropharm OAO. Business daily Vedomosti reported that Sistema could pay between RUB 4.9 billion ($155 million) and RUB 5.7 billion to buy a 51.8% stake in Veropharm OAO from drug store group Aptechnaya set' 36,6 OAO (Pharmacy Chain 36.6). 

Company Quote

850.5
-9.5 -1.10%
20 Sep 2012